LMG Life Sciences Awards EMEA 2023: key dates revealed

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2023: key dates revealed

LMG-LS-2023-EMEA-logo-article

Key dates for the LMG Life Sciences research for 2023 have been released

The LMG Life Sciences Awards EMEA is excited to announce its return and reveal its key dates for 2023. The Awards, the preeminent industry event for legal work in the life sciences sector, will be open for submissions from December 8.

Please mark the following dates in your calendars:

LMG LS EMEA Dates.PNG

The life sciences industry will be invited to submit nominations for leading practitioners, firms, cases, and deals. The Awards will recognise the most outstanding work completed by private practice firms, as well as in-house legal teams and counsels during 2022.

If you have any questions about the research, please contact the LMG Life Sciences awards editor John Harrison.

 

LMG Life Sciences

LMG Life Sciences produces the most respected awards programme for life sciences practitioners and law firms across Europe, the Middle East, and Africa. Honourees are determined through a rigorous research process that aims to recognise and celebrate excellent legal work and client service over a 12-month period.

The awards span four broad practice areas: regulatory, intellectual property, financial & corporate, and non-IP litigation & enforcement.

In addition to award categories for firms and individuals, an array of unique awards are announced each year to highlight the achievements of in-house teams and to celebrate Impact Cases and Deals of the Year.

LMG Life Sciences is a sister publication to Managing IP and IP Stars.

more from across site and SHARED ros bottom lb

More from across our site

Deals between five more law firms and President Trump and an antitrust lawsuit against Amgen were also among the top talking points this week
US counsel explain how they win new cleantech IP business and how they’re navigating the industry’s challenges
Leaders at the IP firms, which have joined forces with backing from a PE investor, share their vision of building the number one pan-European IP practice
Firms will steer clients towards other ways of getting quicker examinations, but fear the ramifications of the USPTO’s decision
Melissa Haapala added that returning to client advocacy and the chance to work on patent litigation were reasons for returning to private practice
Michelle Clark, who has a generalist litigation background, plans to focus on IP disputes at Alston & Bird
Philips and Vivo have entered into a licensing agreement, putting an end to a five-year-old telecom SEP dispute in India
Stefan Müller discusses managing deadlines, the importance of reflection, and why IP is more than just a 'nice to have'
The three founders of the IP firm’s new US offering say they plan to offer a unique proposition in a market fixated by the billable hour
The opinion provides useful guidance when it comes to how courts might consider contributory infringement, DMCA claims, and other issues in AI copyright cases
Gift this article